A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.
Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has ...
For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with ...
A 75-year-old man with poorly differentiated adenocarcinoma in the right lower lobe received neoadjuvant carboplatin, paclitaxel, and nivolumab therapy. Although posttreatment CT scans suggested ...
Marla Anderson, MD, FACS, is a board-certified surgeon who specializes in the surgical treatment of breast disease. Breast cancer is a type of cancer that starts growing in the breast tissue.
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...
While the study reached statistical significance, a <1-month improvement is not clinically significant. With the availability of mTOR, PI3CA, and AKT inhibitors, clinical trials need to consider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results